IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This is a prospective observational study of 30 adult CIDP patients who receive home IVIg
infusion services from AxelaCare Health Solutions, LLC. The decision to treat with IVIg will
be entirely at the discretion of the patient's treating physician.
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute
Collaborators:
AxelaCare Health Solutions, LLC BriovaRx Infusion Services CSL Behring